Multi-omic assessment using proteins and nucleic acids
US12334190B2 · kind B2 · utility
0Cited by
18References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2022 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Mar 30, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2570/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described herein are methods such as multi-omic methods for assessing a disease such as cancer. The multi-omic methods may integrate proteomic, transcriptomic, genomic, lipidomic, or metabolomic data. The method screening diseases or disease states. Also described herein are methods for screening for diseases or disease states from biological samples. The methods may include assessing whether a nodule, mass, or cyst is cancerous.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.